Lavipharm S.A. announces, according to the Resolution No. 3/347/12.7.2005 of the Board of Directors of the Capital Market Commission and Article No 14 of Law 3556/2007, that Dr. Athanase Lavidas, son of Telemaque, Chairman and CEO of Lavipharm S.A., has transferred to "T&A Holdings (Luxembourg) S.a.r.l.", a company of his own interests, 886.031 common Lavipharm shares, amounting to 1.630.297,04 Euros, on Thursday, June 19, 2008. Following to the abovementioned transaction, T&A Holdings (Luxembourg) S.a.r.l. voting rights reached 13,28% of Lavipharm SA's total voting rights, i.e. 6.784.081 shares.